Product Images Rytary

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Rytary NDC 60846-664 by Amneal Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

1 - rytary carbidopa and levodopa extended release cap 1

1 - rytary carbidopa and levodopa extended release cap 1

1 - rytary carbidopa and levodopa extended release cap 2

1 - rytary carbidopa and levodopa extended release cap 2

1 - rytary carbidopa and levodopa extended release cap 3

1 - rytary carbidopa and levodopa extended release cap 3

This is a medication description for extended-release capsules containing 23.75 mg of carbidopa and 95 mg of levodopa. The recommended dosage should be followed as per the package insert. The capsules should be stored in a tightly closed, light-resistant container between 15°C to 30°C (59°F to 86°F). It is important to keep this medication out of reach of children and protected from light and moisture. The manufacturer is Amneal Pharmaceuticals, and it is distributed by Amneal Specialty, a division of Amneal Pharmaceuticals LLC. Note that this product is only available by prescription.*

2 - rytary carbidopa and levodopa extended release cap 4

2 - rytary carbidopa and levodopa extended release cap 4

Each extended-release capsule of this medication contains 36.25 mg of carbidopa (anhycrous) and 145 mg of levodopa. It is recommended to keep this medication out of children's reach and dispense it in a tightly closed, light-resistant container. The capsules should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication should be protected from light and moisture. It is manufactured by Amneal Pharmaceuticals in India and distributed by Amneal Specialty in the USA. Be sure to consult the package insert for the recommended dosage.*

3 - rytary carbidopa and levodopa extended release cap 5

3 - rytary carbidopa and levodopa extended release cap 5

This text provides important information about RYTARY extended-release capsules containing carbidopa and levodopa, which are typically used in the treatment of certain conditions. The recommended dosage and storage conditions are detailed, emphasizing the need to protect the medication from light and moisture and keep it out of reach of children. The manufacturer and distributor details are also included for reference.*

4 - rytary carbidopa and levodopa extended release cap 6

4 - rytary carbidopa and levodopa extended release cap 6

This text provides detailed information about a medication named RYTARY, which contains a combination of carbidopa and levodopa in extended-release capsules. The recommended dosage, storage instructions, manufacturer information, and distribution details are included. It is essential to keep this medication out of reach of children, store it in a tightly closed container protected from light and moisture, and maintain it within the specified temperature range. For precise dosing instructions, it is advised to refer to the package insert.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.